| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |